Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,109.50    -19.00 (-1.68%)
Bid:
1,108.50
Ask:
1,109.50
Spread: 1.00 (0.09%)
Market Cap: £3.56b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

15 Mar 2018 16:35

RNS Number : 8987H
Persimmon PLC
15 March 2018
 

15 March 2018

Persimmon Plc

 

Director/PDMR Shareholding

 

Persimmon Plc (the "Company") announces that it has been notified that on 14 March 2018 Rachel Kentleton, Non-Executive Director and her husband Neil Thompson, sold 545 shares in the Company which they held jointly at an average price of £25.4621. Neil Thompson subsequently purchased 545 shares for his ISA at an average price of £25.467879.

 

The below notification, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, gives further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Rachel Kentleton and Neil Thompson

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director and Closely associated person of Rachel Kentleton, Non-Executive Director respectively

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

Sale of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£25.4621

545

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

14/03/2018

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON); Main Market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 Neil Thompson

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Closely associated person of Rachel Kentleton, Non-Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£25.467879

545

d)

 

Aggregated information

- Aggregated volume

N/A Single Transaction

- Price

N/A Single Transaction

e)

 

Date of the transaction

 

14/03/2018

f)

 

Place of the transaction

 

London Stock Exchange (XLON); Main Market

 

Tracy Davison

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAKDSFDLPEFF
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.